Treat Arterial Hypertension and Diabetes in Rural Africa
TAHADIRA
A Prospective Randomised Trial Comparing Three Interventions to Improve Treatment Adherence Among Patients With Arterial Hypertension or Diabetes in Rural Cameroon (TAHADIRA-trial 1)
1 other identifier
interventional
223
1 country
1
Brief Summary
The purpose of this study is to determine the efficacy of three different interventions to improve treatment adherence among patients with arterial hypertension or diabetes in rural Cameroon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Aug 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 29, 2008
CompletedFirst Posted
Study publicly available on registry
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedMay 27, 2010
August 1, 2009
1.5 years
August 29, 2008
May 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients with regular follow-up one year after the treatment was started
One patient year
Secondary Outcomes (3)
Percentage of missed control-visits
One patient year
Treatment response of diabetic patients (fasting blood glucose)
One patient year
Treatment response of patients with arterial hypertension (blood pressure)
One patient year
Study Arms (3)
1
ACTIVE COMPARATOR2
ACTIVE COMPARATOR3
ACTIVE COMPARATORInterventions
Patients signs in for a agreement - to respect a regular follow-up at the health facility.
The local health committee sends out a member to trace the patient and to motivate him to take up again regular treatment visits.
Eligibility Criteria
You may qualify if:
- Patients with newly diagnosed arterial hypertension or non insulin dependent diabetes type 2 which require treatment and can be treated in the health centre
- Informed consent by the patient
You may not qualify if:
- Patient already under treatment
- Patients who need to be referred to a hospital
- No informed consent by the patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical districts of Mfou, Mbankomo Obala and Esse in Central Cameroon
Divisions of Mefou and Lékié, Central Province, 4056, Cameroon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Engelbert Manga, MD, MPH
Medical district officer of Mfou, Ministry of public health of Cameroon
- PRINCIPAL INVESTIGATOR
Niklaus D Labhardt, MD
Representant of the foundation Coopération Afrique, Switzerland
- STUDY CHAIR
Beat Stoll, MD, MPH
Institute of social and preventive medicine, University of Geneva, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 29, 2008
First Posted
September 1, 2008
Study Start
August 1, 2008
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
May 27, 2010
Record last verified: 2009-08